IRCT2014092819319N1已完成3 期
To assess the efficacy of sub-conjunctival Bevacizumab (Avastin) injection in treatment of primary fleshy pterygium (based on TAN grading) in patients with bilateral primary fleshy pterygium in comparison with sham injection
Vice chancellor for research, Iran University of Medical Science0 个研究点目标入组 40 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 40
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 years 至 70 years（—）
- 性别
- All
入选标准
- •Patients with 20 to 70 years old, with primary bilateral fleshy pterygium invading between 1 to 4 mm into the cornea.
- •Exclusion criteria: Any evidence of cancer or other ocular diseases except refraction errors (including anterior segment and posterior segment), diabetic patients and pregnancy.
排除标准
- 未提供
研究者
相似试验
已完成
不适用
Assessment of subconjunctival bevacizumab effect on the postoperative healing course and recurrence of excised pterygiumpterygium.corneal degenerationIRCT138805192326N1Vice-chancellery of Research Affairs of Shiraz University of Medical Sciences32
已完成
2 期
Safety and efficacy of intra-vitreal bevacizumab combined with supra-choroidal triamcinolone in the treatment of central retinal vein occlusion.Macular edemaEye - Diseases / disorders of the eyeCentral retinal vein occlusionACTRN12622000267752Salahuddin34
已完成
3 期
Comparison of intravitreal Bevacizumab (Avastin) injection alone or in combination with Diclofenac in the treatment of diabetic macular edemaDiabetic retinopathy.Diabetic retinopathyIRCT201512144786N3Isfahan University of Medical Sciences68
已完成
不适用
Safety and effectiveness of intravitreal bevacizumab and ranibizumab injections for treatment of retinal disease patients: an observational studyretinal diseases or conditions that can be treated with bevacizumab or ranibizumab such as neovascular age-related macular degeneration (neovascular AMD),diabetic macular edema (DME),and macular edeneovascular age-related macular degeneration (neovascular AMD)diabetic macular edema (DME)retinal vein occlusion(RVO)TCTR20141002001Health Intervention and Technology Assessment Program (HITAP)6,399
已完成
不适用
Safety and Effectiveness of Subconjunctival Injection of Bevacizumab in the Treatment of Corneal NeovasculizationLipid KeratopathyPenetrating KeratoplastyHerpetic KeratopathyRosaceaNCT00681603National Taiwan University Hospital13